🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I dose escalating study of oral satraplatin in combination ...
Status
Completed
Location
Yale University, Comprehensive Cancer Center
Start Date
2007-05
Trial ID
NCT00473720
Treatments Being Tested
The purpose of this trial is to study the combination regimen of satraplati...
Status
Completed
Location
Sarah Cannon Research Institute
Start Date
2005-12
Trial ID
NCT00268970
Treatments Being Tested
This is a single center, open-label, non-randomized, Phase I dose finding s...
Status
Terminated
Location
University of Wisconsin Comprehensive Cancer Center
Start Date
2007-03
Trial ID
NCT00125411
Treatments Being Tested
The SPERA trial is designed to 1. provide satraplatin to physicians with pa...
Status
Terminated
Location
Carraway Cancer Clinic
Start Date
2007-02
Trial ID
NCT00450970
Treatments Being Tested
Patients ≥ 70 years of age with locally advanced unresectable or metastatic...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2006-07
Trial ID
NCT00370383
Treatments Being Tested
Current agents administered in therapeutic regimens of prostate cancer empl...
Status
Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2015-01
Trial ID
NCT03258320
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2007-10
Trial ID
NCT00499694
Treatments Being Tested
PURPOSE: This trial is designed to compare the combination of the investiga...
Status
Terminated
Location
Southwestern Medical Center
Start Date
2004-08
Trial ID
NCT00093132
Treatments Being Tested
Vinorelbine (NVB) and platinum compounds are anticancer agents with broad s...
Status
Unknown
Location
Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni
Start Date
2008-02
Trial ID
NCT01220284
Treatments Being Tested
This is a single-center, open-label (sequential-group dose-escalation dose-...
Status
Terminated
Location
Sarah Cannon Research Institute
Start Date
2006-03
Trial ID
NCT00313456
Treatments Being Tested